AI for Drug Repurposing: A Hypothesis-First Workflow
AI can surface repurposing hypotheses from literature and omics data, but clinical proof stays human. A workflow for researchers and biotech teams.
Blog
Insights, guides, and latest trends from the world of AI tools
Latest Blogs
-
-
Genomic Language Models: DNA Chatbots and What They Actually Do
Models like Evo and GPN-Star treat DNA as language. Learn how genomic LMs differ from chat LLMs and where they appear in research tools.
-
AI Protein Design Beyond Folding: What Changed in 2026
Structure prediction was step one. Generative protein design now targets function, binding, and manufacturability. What researchers and tool buyers should know.
-
What a Simulated Fly Brain Teaches AI Architects
The complete male fruit fly connectome is being simulated in games and AI experiments. What 166,000 neurons reveal about scaling agent architectures.
-
When the Model Eats the Stack: What the Bitter Lesson Means for Data Tools
As LLMs internalize capabilities, engineered data-agent layers get absorbed. Researchers argue persistent semantic context is what survives. What tool buyers should watch.
-
SoftBank OpenAI Stake Follow-On: 2026 Investment News and Governance
SoftBank reportedly adjusted its OpenAI stake amid IPO rumors. Track investment terms, governance rights, and market reactions.
-
Texas AI Government Use Transparency Bill: 2026 Requirements
Texas advanced transparency rules for government AI use. Summarize disclosure duties, procurement rules, and vendor obligations.
-
Liquid Cooling for AI Racks: 2026 Data Center Adoption News
AI racks pushed liquid cooling mainstream in 2026. Vendor moves, TCO math, and facility retrofit challenges for operators.
-
AI Consolidation and M&A Deals in 2026: Who Bought Whom
AI M&A accelerated as incumbents bought agents, data, and chips. Roundup of notable deals and what consolidation means for buyers.
Didn't find tool you were looking for?